Innate Pharma IPHA
NASDAQ IPHA
$1.57 -0.01 (-0.44%)
As of: Oct 21, 2026 · 10:41 AM EDT

Innate Pharma (IPHA) Non-cash Items (2019 - 2025)

Updated

Innate Pharma (IPHA) recorded Non-cash Items of -$49.03 million in the quarter ended Dec 31, 2025, compared with -$49.22 million a year earlier.

Analysis

Innate Pharma (IPHA) Non-cash Items (2019 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma reported Non-cash Items of -$47.59 million.

  • Across earlier years, Non-cash Items came in at -$49.85 million in the year ended Dec 31, 2024, -$505,162 in the year ended Dec 31, 2023, -$7.01 million in the year ended Dec 31, 2022 and -$55.57 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2025 is the highest quarterly Non-cash Items since the quarter ended Jun 30, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.10 Bn 1,100.69 Bn 19.71 Bn
2 Johnson & Johnson 615.67 Bn 534.20 Bn 17.26 Bn
3 AbbVie 504.61 Bn 477.72 Bn 12.70 Bn
4 Merck 368.03 Bn 322.41 Bn 12.21 Bn
5 Novartis Ag 298.24 Bn 262.23 Bn 11.24 Bn
6 Astrazeneca 261.77 Bn 235.46 Bn 12.86 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.81 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Innate Pharma 140.75 Mn -66.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -49.03 Mn
Dec 31, 2024 -49.22 Mn
Jun 30, 2024 -25.37 Mn
Dec 31, 2023 -502,463.94
Dec 31, 2022 -6.79 Mn
Dec 31, 2021 -55.57 Mn
Jun 30, 2021 -22.31 Mn
Dec 31, 2020 -3.05 Mn
Jun 30, 2020 -473,627.86
Dec 31, 2019 -5.89 Mn
API Access

Innate Pharma Non-cash Items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-cash-items&ticker=IPHA&period=max&api_key=YOUR_API_KEY